UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

An update on larynx cancer

CA: a cancer journal for clinicians, 2017-01, Vol.67 (1), p.31-50

2017

Volltextzugriff (PDF)

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

The lancet oncology, 2019-09, Vol.20 (9), p.1295-1305

2019

Volltextzugriff (PDF)

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer

Cancer discovery, 2022-01, Vol.12 (1), p.74-89

2022

Volltextzugriff (PDF)

ALK‐positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options

Cancer, 2014-08, Vol.120 (16), p.2392-2402

2014

Volltextzugriff (PDF)

The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer

Cancer, 2015-04, Vol.121 (8), p.E1-E6

2015

Volltextzugriff (PDF)

MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation

Cancer cell, 2018-08, Vol.34 (2), p.315-330.e7

2018

Volltextzugriff (PDF)

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

BMC cancer, 2019-08, Vol.19 (1), p.857-857, Article 857

2019

Volltextzugriff (PDF)

Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium

Cancer, 2016-03, Vol.122 (5), p.766-772

2016

Volltextzugriff (PDF)

Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population

The Laryngoscope, 2021-03, Vol.131 (3), p.E921-E928

2021

Volltextzugriff (PDF)

Atypical Carcinoid Tumor of the Lung: A Surveillance, Epidemiology, and End Results Database Analysis

Journal of thoracic oncology, 2015-03, Vol.10 (3), p.479-485

2015

Volltextzugriff (PDF)

Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma

Clinical lung cancer, 2016-09, Vol.17 (5), p.e57-e64

2016

Volltextzugriff (PDF)

Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005

Cancer, 2016-01, Vol.122 (1), p.50-60

2016

Volltextzugriff (PDF)

Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base

Clinical lung cancer, 2017-05, Vol.18 (3), p.286-292

2017

Volltextzugriff (PDF)

An update on the immune landscape in lung and head and neck cancers

CA: a cancer journal for clinicians, 2020-11, Vol.70 (6), p.505-517

2020

Volltextzugriff (PDF)

T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma

Journal for immunotherapy of cancer, 2022-06, Vol.10 (6), p.e004512

2022

Volltextzugriff (PDF)

A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer

Cancers, 2022-05, Vol.14 (11), p.2639

2022

Volltextzugriff (PDF)

Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma

O.R.L. Journal for oto-rhino-laryngology and its related specialties, 2023-04, Vol.85 (2), p.80-87

2023

Volltextzugriff (PDF)

Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: “Repeat and replicate”

Cancer, 2022-12, Vol.128 (24), p.4177-4178

2022

Volltextzugriff (PDF)

A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2017-11, Vol.109 (11)

2017

Volltextzugriff (PDF)

The End of Nihilism: Systemic Therapy of Advanced Non-Small Cell Lung Cancer

Annual review of medicine, 2017-01, Vol.68, p.153

2017

Volltextzugriff (PDF)

Targeting EGFR in lung cancer: Lessons learned and future perspectives

Molecular aspects of medicine, 2015-11, Vol.45, p.67-73

2015

Volltextzugriff (PDF)

Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis

International journal of radiation oncology, biology, physics, 2020-09, Vol.108 (1), p.304-313

2020

Volltextzugriff (PDF)

HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?

Current treatment options in oncology, 2022-03, Vol.23 (3), p.325-332

2022

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(100)

Sprache

Englisch
(100)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

An update on larynx cancer

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer

ALK‐positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options

The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer

MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium

Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population

Atypical Carcinoid Tumor of the Lung: A Surveillance, Epidemiology, and End Results Database Analysis

Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma

Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005

Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study

An update on the immune landscape in lung and head and neck cancers

T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma

A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer

Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma

Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: “Repeat and replicate”

A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer

The End of Nihilism: Systemic Therapy of Advanced Non-Small Cell Lung Cancer

Targeting EGFR in lung cancer: Lessons learned and future perspectives

Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis

HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy

Suchergebnisse filtern